Aurobindo Pharma receives US FTC approval for acquisition of Lannett business
Mumbai, June 19 -- Aurobindo Pharma announced that its wholly owned subsidiary, Aurobindo Pharma USA Inc. has received the approval from US Federal Trade Commission (FTC) for the acquisition of 100% of membership interest in Lannett Company LLC from LANNETT SELLER HOLDCO, INC.
Published by HT Digital Content Services with permission from Capital Market....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.